Drug Discovery 2021 After the Storm: Re-connect, Re-invent, Re-imagine

Sunday 19 November
20 November
[Schedule with Sessions only]
All times shown are GMT —
DAY 1Room 3ARoom 3BHall 1BHall 1CRoom 11B - WorkshopCareers Zone, Main Exhibition Hall
DAY 2
08:00 Event Registration
Early Career Professional Welcome

Early Career Professional Welcome
08:00 (45 mins)
Lisa Stott, Sosei Heptares   
08:00
08:05 08:05
08:10 08:10
08:15 08:15
08:20 08:20
08:25 08:25
08:30 08:30
08:35 08:35
08:40 08:40
08:45
ELRIG - Opening Session

ELRIG - Annual Review - Visons & Values
08:45 (10 mins)
Melanie Leveridge, GSK  

ELRIG - Equality, Diversity & Inclusion Guiding Principals
08:55 (5 mins)
Clare Viney, Vitae  

ELRIG - Lifetime Achievement Award - A Career In Drug Discovery
09:00 (20 mins)
Steve Rees, AstraZeneca  
Innovation and Automation during a Pandemic
09:20 (50 mins)
Rob Howes, DHSC  
Platinum Sponsorship Presentation
08:45
08:50 08:50
08:55 08:55
09:00 09:00
09:05 09:05
09:10 09:10
09:15 09:15
09:20 09:20
09:25 09:25
09:30 09:30
09:35 09:35
09:40 09:40
09:45 09:45
09:50 09:50
09:55 09:55
10:00 10:00
10:05 10:05
10:10 Refreshment Break 10:10
10:15 10:15
10:20 10:20
10:25 10:25
10:30 10:30
10:35 10:35
10:40 10:40
10:45 10:45
10:50
New Approaches in Infection Biology
Chairs: David Pallin, CRL  Adrian Goldman, U. Helsinki  
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd
Chairs: Nikki Carter, Excalibur Healthcare  Emily Adams, Liverpool School of Tropical Medicine and Mologic   
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Chairs: Wesley Blackaby, Servier  Oliver Rausch, Storm Therapeutics Ltd  
Alzheimer’s Research UK
Chairs: John Isaac, Janssen Neuroscience  David Reynolds, AstronauTx Ltd  
Workshop

Gaining a career in industry: Learning tips and tricks from the inside
10:50 (60 mins)
Allan Jordan, Sygnature Discovery  
10:50
10:55 10:55
11:00
New Approaches in Infection Biology

Neuropilin-1 facilitates SARS-CoV2 cell entry and infectivity
11:00 (30 mins)
Maria Anastasina, University of Helsinki  
Diverse neutralizing SARS-CoV-2 antibodies identified from large-scale synthetic phage libraries target rare epitopes and retain binding to variants of concern.
11:30 (30 mins)
Tom Yuan — Twist Bioscience    
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

Q-POCTM, a paradigm shift in rapid multiplex molecular diagnostics
11:00 (30 mins)
Jonathan OHalloran, QuantumDx  
Transforming Drug Discovery Through Precision Research
11:30 (30 mins)
Stephen Hague — 10x Genomics    
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

Discovery of risdiplam (evrysdi) - A medicine for the treatment of spinal muscular atrophy
11:00 (30 mins)
Hasane Ratni , F. Hoffmam-La Roche  
A Fully Automated Data Analysis Workflow for Gene Expression-Based Screening
11:30 (30 mins)
Gabriela Nass Kovacs — Genedata AG    
Alzheimer’s Research UK

Alzheimer’s Research UK and its support for translational research.
11:00 (30 mins)
Sara Imarisio, ARUK  
Coding cells for health: building translational disease models for drug discovery and therapeutics
11:30 (30 mins)
Sara Gomes — bit.bio    Marta Rucka — bit.bio    
11:00
11:05 11:05
11:10 11:10
11:15 11:15
11:20 11:20
11:25 11:25
11:30 11:30
11:35 11:35
11:40 11:40
11:45 11:45
11:50 11:50
11:55 11:55
12:00
New Approaches in Infection Biology

Functional analysis of Bartonella pathogenicity factors might contribute to novel therapeutic concepts
12:00 (30 mins)
Volkhard Kempf , Goethe University of Frankfurt am Main  
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

A luminescent reporter cell line for authentic SARS-CoV-2 infection and neutralising antibody activity
12:00 (30 mins)
Nick Matheson, University of Cambridge  
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

mRNA Lightning platform for the discovery of selective small molecule mRNA regulatory drugs
12:00 (30 mins)
Iris Alroy, Anima Biotech  
Alzheimer’s Research UK

Identification of tool compounds targeting the SRSF1-dependent nuclear export of pathological C9ORF72-repeat transcripts
12:00 (30 mins)
Lianne Van Beek, CRL  Tennore Ramesh, Sheffield Institute for Translational Neuroscience (SITraN)  
12:00
12:05 12:05
12:10 12:10
12:15 12:15
12:20 12:20
12:25 12:25
12:30 Refreshment Break
Workshop
Chairs: Lilian Hunt, EDIS, Wellcome Trust  

Inclusive research and experimental design
12:30 (60 mins)
Lilian Hunt, EDIS, Wellcome Trust  
12:30
12:35 12:35
12:40 12:40
12:45 12:45
12:50 12:50
12:55 12:55
13:00 13:00
13:05 13:05
13:10 13:10
13:15 13:15
13:20 13:20
13:25 13:25
13:30 13:30
13:35 13:35
13:40 13:40
13:45 13:45
13:50 13:50
13:55 13:55
14:00
New Approaches in Infection Biology

Targeting the human RED-SMU1 splicing complex as a basis for host-directed anti-influenza therapy
14:00 (30 mins)
Nadia Naffakh, Institut Pasteur, CNRS  
Introducing TRFID, a UK-leading BSL3 translation biology facility for Infectious Diseases at Alderley Park
14:30 (5 mins)
Helen Bright — Medicines Discovery Catapult    
LabLogic Life Sciences range has something for everyone
14:35 (5 mins)
Lucy Farmer — LabLogic Systems Limited    
FidaBio: Characterizing Biomolecular behaviour by measuring and monitoring changes in hydrodynamic radius
14:40 (5 mins)
Jo Walter — Fida Biosystems ApS    
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

Diagnostics for epidemics, pandemics and neglected tropical disease
14:00 (30 mins)
Emily Adams, Liverpool School of Tropical Medicine and Mologic   
Mesoporous silica & PLGA nanoparticles for next-generation drug delivery & targeted therapeutic technologies
14:30 (5 mins)
Philippe Saint-Cricq-Riviere — nanoComposix    
Assist Plus
14:35 (5 mins)
Sharon Barnard — INTEGRA Biosciences    
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

Dynamic RNAs and Structure-Guided Small Molecule Drug Discovery
14:00 (30 mins)
Isaac Kimsey, Nymirum  Yang Zheng, Nymirum  
DNA-Encoded Library Technology for Drug Discovery
14:30 (5 mins)
Assunta Romano — Merck Life Science    
Alzheimer’s Research UK

Small molecule inhibitors of carboxylesterase Notum to potentiate Wnt signalling
14:00 (30 mins)
Nicky Willis, UCL DDI  
Quantifying Morphological Change Using Label-Free Live-Cell Analysis
14:30 (15 mins)
Jasmine Trigg — Sartorius     
Workshop
Chairs: Anita Ramanathan, Word Cortex  

Exceptional Science Presentations: How to Effectively Communicate the Value of Your Work
14:00 (45 mins)
Anita Ramanathan, Word Cortex  
14:00
14:05 14:05
14:10 14:10
14:15 14:15
14:20 14:20
14:25 14:25
14:30 14:30
14:35 Tecan UK Ltd
14:35
14:40
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Integrated Drug Discovery: Chemistry and Biology working together to create innovative solutions
14:40 (5 mins)
Catherine Stace — Domainex    
14:40
14:45
New Approaches in Infection Biology

Studies of the membrane-bound pyrophosphatase as a potential drug target against protist parasites
14:45 (30 mins)
Keni Vidilaseris, University of Helsinki  
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

EMERGING DIAGNOSTIC TECHNOLOGIES IN CLINICAL MICROBIOLOGY
14:45 (30 mins)
Alex Van Belkum, Biomeirieux  
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

Small activating RNAs from concept to Phase 2 clinical trial
14:45 (30 mins)
Vikash Reebye  Nagy Habib , MiNA Therapeutics  
Alzheimer’s Research UK

Development of eIF2B modulators for the treatment of neurodegenerative disease
14:45 (30 mins)
Duncan Scott, Alborada Drug Discovery Institute, Cambridge  
14:45
14:50 14:50
14:55 14:55
15:00 15:00
15:05 15:05
15:10 15:10
15:15 Refreshment Break 15:15
15:20 15:20
15:25 15:25
15:30 15:30
15:35 15:35
15:40 15:40
15:45
New Approaches in Infection Biology

Developing inhibitors that block adhesin-collagen interactions
15:45 (30 mins)
Dirk Linke, University of Oslo  
PerkinElmer’s Tools to study virus-host interaction and virus inhibition
16:15 (15 mins)
Louise Affleck — PerkinElmer    
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

Computer literate? Novel AI based reading of lateral flow devices
15:45 (30 mins)
Daniel Wise, Excalibur Healthcare  
Design your molecular-based assays with confidence: Using ATCC’s Genome Portal bioinformatics platform to select wide-ranging, sequence-verified materials
16:15 (5 mins)
Rebecca Charlton — LGC - ATCC    
Don't Let the Antibody be a Variable in Your Assay
16:20 (5 mins)
Mark Twigden — Cell Signaling Technology    
Introducing Cytek cFluorTM Reagents and Assays
16:25 (5 mins)
Michelle Jackson — Cytek Bio    
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

Drugging RNA Modifying Enzymes – METTL3 Inhibitors as a novel therapeutic strategy for Acute Myeloid Leukemia
15:45 (30 mins)
David Hardick, Storm Therapeutics  Konstantinos Tzelepis , The Milner Therapeutics Institute  
Alzheimer’s Research UK

Gene editing to treat expanded CAG/CTG repeat disorders
15:45 (30 mins)
Vincent Dion, Cardiff Dementia Research Institute  
The new generation of live cell shipments
16:15 (5 mins)
Simon Myrbäck — Cellbox Solutions    
High-Throughput Genome Editing for Disease Models
16:20 (5 mins)
Nick Clare — Synthego     
Ulysses - Arctoris' end-to-end automation platform for accelerated drug discovery
16:25 (5 mins)
Daniel Thomas — Arctoris Ltd    
Workshop
How to select the best nanoparticle for next-gen drug delivery
15:45 (60 mins)
Philippe Saint-Cricq-Riviere — nanoComposix    
15:45
15:50 15:50
15:55 15:55
16:00 16:00
16:05 16:05
16:10 16:10
16:15
Technology Spotlights
16:15
16:20 16:20
16:25 16:25
16:30
New Approaches in Infection Biology

Inhibition of bacterial virulence as an alternative to antibiotic treatment: Pseudomonas aeruginosa elastase as a target for antivirulence therapy
16:30 (30 mins)
Martin Everett, Antabio  
Diagnostic Testing and Biomarkers - The New Normal? - sponsored by Ziath Ltd

How to build a mobile lab for genomic surveillance of viral outbreaks
16:30 (30 mins)
Joshua Quick, Institute of Microbiology and infection, University of Birmingham  
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA

X-reactivation as an approach to treating Rett Syndrome
16:30 (30 mins)
Jeannie Lee, Harvard  
Alzheimer’s Research UK

Novel Therapeutic Targets for Treatment of Neurodegeneration
16:30 (30 mins)
Paul Brennan, Oxford DDI   
16:30
16:35 16:35
16:40 16:40
16:45 16:45
16:50 16:50
16:55 16:55
17:00 Networking & Posters 17:00
17:05 17:05
17:10 17:10
17:15 17:15
17:20 17:20
17:25 17:25
17:30 17:30
17:35 17:35
17:40 17:40
17:45 17:45
17:50 17:50
17:55 17:55
18:00 18:00
18:05 18:05
18:10 18:10
18:15 18:15
18:20 18:20
18:25 18:25
18:30 18:30
18:35 18:35
18:40 18:40
18:45 18:45
18:50 18:50
18:55 18:55
19:00 19:00